ABC
1Main
2Brand NameGSK1349572
3EconomicsShionogi
4MechanismIntegrase inhibitor
5IndicationHIV
6SeriesGSK1265744 discontinued
7DosingQD without boosting
8Clinical Trials
9Phase II monotherapy n=35
10Day 10 saw 1.5-2.5log drop.